Oramed Pharmaceuticals, Inc. has signed a manufacturing agreement with Swiss Caps AG for the manufacture of gel capsules for its Phase I trials. In lieu of a cash payment, Swiss Caps offered a straight equity exchange for its services and will be paid in shares. This followed a due diligence process and an in-depth review of Oramed’s oral delivery technology, according to a Swiis Caps statement. “This type of agreement means cooperation with Swiss Caps rather than just out-servi...